 |
Glycaemic
impact of patient-led use of sensor-guided pump therapy in type
1 diabetes |
| |
Individuals established on insulin pump therapy
can employ sensor-guided pump management to improve glycaemic control
( Diabetologia) |
| |
|
|
CD4+
CD25+ T cells control autoimmunity in the absence of B cells |
| |
BAFF/APRIL blockade prevents diabete (Diabetes) |
| |
|
|
Amylin
seeks FDA OK on once-weekly diabetes drug |
| |
Biotechnology company Amylin Pharmaceuticals
has applied for Food and Drug Administration approval of its once-weekly
diabetes treatment (Associated Press) |
| |
|
